Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Current Deferred Revenue (2018 - 2022)

Zai Lab's Current Deferred Revenue history spans 5 years, with the latest figure at $26.9 million for Q1 2022.

  • For Q1 2022, Current Deferred Revenue rose 61.47% year-over-year to $26.9 million; the TTM value through Mar 2022 reached $26.9 million, up 61.47%, while the annual FY2021 figure was $27.5 million, 63.04% up from the prior year.
  • Current Deferred Revenue for Q1 2022 was $26.9 million at Zai Lab, down from $27.5 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $27.5 million in Q4 2021 and bottomed at $2.1 million in Q4 2018.
  • The 5-year median for Current Deferred Revenue is $17.2 million (2020), against an average of $16.0 million.
  • The largest annual shift saw Current Deferred Revenue skyrocketed 39.58% in 2019 before it skyrocketed 485.14% in 2020.
  • A 5-year view of Current Deferred Revenue shows it stood at $2.1 million in 2018, then surged by 39.58% to $2.9 million in 2019, then surged by 485.14% to $16.9 million in 2020, then soared by 63.04% to $27.5 million in 2021, then dropped by 2.15% to $26.9 million in 2022.
  • Per Business Quant, the three most recent readings for ZLAB's Current Deferred Revenue are $26.9 million (Q1 2022), $27.5 million (Q4 2021), and $17.5 million (Q3 2021).